Studies on the Renal Kinetics of Growth Hormone (GH) and on the GH Receptor and Related Effects in Animals

Growth hormone (GH) is filtered through the kidney, and may exert effects on renal function when presented via the circulation. Investigations on kidney-related aspects of GH are increasing in number. Using in vitro and in vivo approaches, the present study attempted to provide answers to a number of unresolved or debated issues. In vitro, we detected both GH and type 1 IGF receptors (R) in a porcine renal epithelial cell line. The saturation and down regulation kinetics of the GH-R indicate that it has the properties of a classical GH-R. Furthermore, the simultaneous presence of GH-R and IGF-R on a phenotypically homogeneous cell line suggests the presence of GH-induced auto-/paracrine IGF-1 bioactivity in the kidney. Experiments with isolated proximal rabbit tubules incubated with physiological concentrations of 125I-GH demonstrated a time-and dose-dependent increase in unlabelled GH-displaceable cell-associated radioactivity, lending support to the concept of GH mediating its renal effects via proximal tubular GH-R. Short term administration of GH to rats and humans elicited electrolyte and water retention that may cause edema in adults. In the present study, long term administration of GH to rats caused only a minor increase in serum phosphate levels, with no changes observed in the renal electrolyte clearance. During the first 4 days of GH treatment in rats, no change in plasma renin activity was detected and we were thus unable to confirm the hypothesis that the renin-angiotensin system is responsible for the early phase of GH-associated fluid retention. Pharmacokinetically, when GH was administered to rats with functional disconnection of the kidneys as a model of renal insufficiency, the whole body clearance of GH decreased by ca. two thirds, and was reflected by an increase in the mean residence time and AUCplasma for GH. The plasma half-life, however, was not significantly affected, suggesting that the volume of distribution (Vd) had decreased for the GH administered to the renally compromised animals. A renal contribution to the Vd was visualized as intense radioactive staining in the kidney region on whole body autoradiographs (WBA) of rats dosed with 125I-labelled hGH. The liver region was also intensely stained. Kidney-associated radioactivity was found to be related not only to glomerular filtration, but also to peritubular uptake, since the renal clearance of free GH was found to exceed the GFR.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  U. Hedner,et al.  Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor. , 1993, Pharmacology & toxicology.

[2]  L. F. Chasseaud,et al.  Distribution of the Recombinant Coagulation Factor 125I-rFVIIa in Rats , 1993, Thrombosis and Haemostasis.

[3]  P. Hindmarsh,et al.  Blood pressure and the renin‐angiotensin‐aldosterone system in children receiving recombinant human growth hormone , 1993, Clinical endocrinology.

[4]  T. Stijnen,et al.  Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure , 1992, Pediatric Nephrology.

[5]  M. Chobanian,et al.  Growth hormone regulates ammoniagenesis in canine renal proximal tubule segments. , 1992, The American journal of physiology.

[6]  A. Fogo,et al.  Effects of Prolonged Growth Hormone Administration in Rats with Chronic Renal Insufficiency , 1992, Pediatric Research.

[7]  M. Baum,et al.  Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. , 1991, The Journal of clinical investigation.

[8]  E. B. Pedersen,et al.  Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. , 1991, The Journal of clinical endocrinology and metabolism.

[9]  B. J. Tucker,et al.  Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. , 1991, The Journal of clinical investigation.

[10]  S. Miller,et al.  Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. , 1990, The American journal of physiology.

[11]  S. Miller,et al.  Growth hormone stimulates IGF I gene expression in isolated rat renal collecting duct. , 1990, The American journal of physiology.

[12]  T. Stijnen,et al.  Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. , 1990 .

[13]  A. Weissberger,et al.  The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. , 1990, Metabolism: clinical and experimental.

[14]  I. Karl,et al.  Growth hormone directly stimulates gluconeogenesis in canine renal proximal tubule. , 1989, The American journal of physiology.

[15]  M. Hammerman The growth hormone-insulin-like growth factor axis in kidney. , 1989, The American journal of physiology.

[16]  S. Rogers,et al.  Growth hormone activates phospholipase C in proximal tubular basolateral membranes from canine kidney. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Clark,et al.  Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. , 1989, Endocrinology.

[18]  J. Kopple,et al.  The delayed effect of growth hormone on renal function in humans. , 1989, Kidney international.

[19]  H. Imura,et al.  Urinary growth hormone levels measured by ultrasensitive enzyme immunoassay in patients with renal insufficiency. , 1988, The Journal of clinical endocrinology and metabolism.

[20]  J. Christiansen,et al.  Kidney function and size in normal subjects before and during growth hormone administration for one week , 1981, European journal of clinical investigation.

[21]  R. Rabkin,et al.  Removal and excretion of immunoreactive rat growth hormone by the isolated kidney. , 1981, The American journal of physiology.

[22]  P. Halban,et al.  Insulin degradation by hepatocytes in primary culture. , 1981, Endocrinology.

[23]  H. Parving,et al.  Kidney function in normal man during short-term growth hormone infusion. , 1978, Acta endocrinologica.

[24]  T. Maack,et al.  Renal extraction, filtration, absorption, and catabolism of growth hormone. , 1977, The American journal of physiology.

[25]  K. Poulsen,et al.  An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. , 1974, The Journal of clinical endocrinology and metabolism.

[26]  R. Rabkin,et al.  Disappearance of Human Growth Hormone 125I in the Anephric Non-Uraemic and Uraemic Rat* , 1972, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[27]  H. Burger,et al.  Metabolic clearance of human growth hormone in patients with hepatic and renal failure, and in the isolated perfused pig liver. , 1972, Metabolism: clinical and experimental.

[28]  P. Forsham,et al.  SODIUM RETENTION WITH HUMAN GROWTH HORMONE AND ITS SUBFRACTIONS , 1961 .

[29]  H. White,et al.  Enhancing effects of growth hormone on renal function. , 1949, The American journal of physiology.

[30]  R. Palmiter,et al.  Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. , 1989, Endocrinology.

[31]  K. Jørgensen Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats. , 1987, Acta endocrinologica.

[32]  Stacy,et al.  Disappearance of 125l-Labelled Rat Growth Hormone in Nephrectomized and Sham Operated Rats , 1975 .